Statins decrease adverse outcomes in coronary artery bypass for extensive coronary artery disease as well as left main coronary stenosis

Cardiovascular Therapeutics

Volumn 28, Issue 2, 2010, Pages 70-79

  Gan, Hui Li ^a   Zhang, Jian Qun ^a   Bo, Ping ^a   Wang, Sheng Xun ^a   Lu, Chun Shang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Coronary artery bypass graft; Left main coronary stenosis (LMS); Statins

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; TROPONIN I;

ADULT; AGED; AORTA BALLOON; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISABILITY; DRUG EFFECT; EMERGENCY SURGERY; FEMALE; FOLLOW UP; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; KIDNEY DYSFUNCTION; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STROKE; SURGICAL MORTALITY; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY ARTERY BYPASS; CORONARY STENOSIS; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PERIOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77749259037     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2009.00098.x     Document Type: Article

References (29)

1. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery. A report of the American College of Cardiology (American Heat Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 1999 100 : 1464 1180.
2. The Society of Cardiothoracic Surgeons of Great Britain and Ireland. Fifth national adult cardiac surgical database report 2003. July 2004.
3. Ferdinard KC. Primary prevention trials: Lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease. Curr Med Res Opin 2005 21 : 1091 1097.
4. Briel M, Nordmann AJ, Bucher HC. Statin therapy for prevention and treatment of acute and chronic cardiovascular disease: Update on recent trials and metaanalyses. Curr Opin Lipidol 2005 16 : 601 605.
5. Clearfield M. Statins and the primary prevention of cardiovascular events. Curr Atheroscler Rep 2006 8 : 390 396.
6. Schouten O, Bax JJ, Dunkelgrun M, Feringa HH, van Urk H, Poldermans D. Statins for the prevention of perioperative cardiovascular complications in vascular surgery. J Vasc Surg 2006 44 : 419 424.
7. Karthikeyan G, Bhargava B. Managing patients undergoing non-cardiac surgery: Need to shift emphasis from risk stratification to risk modification. Heart 2006 92 : 17 20.
8. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006 105 : 1260 1272.
9. Biccard BM, Sear JW, Foex P. Statin therapy: A potentially useful perioperative intervention in patients with cardiovascular disease. Anaesthesia 2005 60 : 1106 1114.
10. Paraskevas KI, Athyros VG, Briana DD, Kakafika AI, Karagiannis A, Mikhailidis DP. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets 2007, 8 : 942 951.
11. Liakopoulos OJ, Dorge H, Schmitto JD, Nagorsnik U, Grabedunkel J, Schoendube FA. Effects of preoperative statin therapy on cytokines after cardiac surgery. Thorac Cardiovasc Surg 2006 54 : 250 254.
12. Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Am J Cardiol 2003 91 : 1107 1109.
13. Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Am J Cardiol 2003 91 : 1107 1109.
14. Dotani MI, Morise AP, Haque R, Jain AC, Gupta N, Gibson CM. Association between short-term simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Am J Cardiol 2003 91 : 1107 1109.
15. Pascual DA, Arribas JM, Tornel PL, et al. Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. Ann Thorac Surg 2006 81 : 78 83.
16. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004 110 : II45 49.
17. Collard CD, Body SC, Shernan SK, Wang S, Mangano DT, Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc. Ischemia Research and Education Foundation (IREF) Investigators. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2006 132 : 392 400.
18. Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 1999 15 : 394 399.
19. Coleman CI, Lucek DM, Hammond J, White CM. Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin 2007 23 : 1783 1790.
20. Aboyans V, Labrousse L, Lacroix P, et al. Predictive factors of stroke in patients undergoing coronary bypass grafting: Statins are protective. Eur J Cardiothorac Surg 2006 30 : 300 304.
21. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994 344 : 563 570. [Erratum, Lancet 1994;344:1446.]
22. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994 344 : 1383 1389.
23. Momin A, Melikian N, Wheatcroft SB, et al. The association between saphenous vein endothelial function, systemic atherosclerosis, and statin therapy in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007 134 : 335 341.
24. Chello M, Spadaccio C, Anselmi A, Patti G, Lusini M, Di Sciascio G, Covino E. Simvastatin reduces CD40 expression in an experimental model of early arterialization of saphenous vein graft. J Surg Res 2006 136 : 302 308.
25. Deglise S, Martin D, Probst H, et al. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia. J Vasc Surg 2005 41 : 1043 1052.
26. Kangasniemi OP, Biancari F, Luukkonen J, Vuorisalo S, Satta J, Pokela R, Juvonen T. Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery. Eur J Cardiothorac Surg 2006 29 : 983 985.
27. Palmerini T, Marzocchi A, Marrozzini C, et al. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. Eur J Cardiothorac Surg 2007 31 : 685 690.
28. Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 2006 24 : 33 50.
29. Field KM. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on high-sensitivity C-reactive protein levels. Pharmacotherapy 2005 25 : 1365 1377.